Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors – GlobeNewswire (press release)
|
Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors
GlobeNewswire (press release) As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the … |
